ACOG Publications

    loading  Checking for direct PDF access through Ovid

Excerpt

PUBLICATIONS | January 2018
PRACTICE GUIDELINES
WITHDRAWN The following College document has been withdrawn:
ACOG Technology Assessment No. 10: Single-Incision Laparoscopy (Obstet Gynecol 2013;122:429– 31)
REVISED The following College documents have been revised:
ACOG Committee Opinion No. 493: Cultural Sensitivity and Awareness in the Delivery of Health Care (Obstet Gynecol 2011;117:1258– 61) has been withdrawn and replaced by Committee Opinion No. 729: Importance of Social Determinants of Health and Cultural Awareness in the Delivery of Reproductive Health Care (Obstet Gynecol 2018;131:e43–8)
ACOG Committee Opinion No. 562: Müllerian Agenesis: Diagnosis, Management, and Treatment (Obstet Gynecol 2013;121:1134– 7) has been withdrawn and replaced by Committee Opinion No. 728: Müllerian Agenesis: Diagnosis, Management, and Treatment (Obstet Gynecol 2018;131:e35–42)
ACOG Practice Bulletin No. 153: Nausea and Vomiting of Pregnancy (Obstet Gynecol 2015;126:e12– 24) has been withdrawn and replaced by Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (Obstet Gynecol 2018;130:e15–30)
ACOG Practice Bulletin No. 172: Premature Rupture of Membranes (Obstet Gynecol 2016;128:165– 77) (Interim Update) has been withdrawn and replaced by Practice Bulletin No. 188: Prelabor Rupture of Membranes (Obstet Gynecol 2018;131:e1–14) (Interim Update)
REAFFIRMED The following College documents have been reaffirmed:
ACOG Committee Opinion No. 375: Brand Versus Generic Oral Contraceptives (Obstet Gynecol 2007;110:447–8)
ACOG Committee Opinion No. 434: Induced Abortion and Breast Cancer Risk (Obstet Gynecol 2009;113:1417–8)
ACOG Committee Opinion No. 484: Performance Enhancing Anabolic Steroid Abuse in Women (Obstet Gynecol 2011;117:1016–8)
ACOG Committee Opinion No. 571: Solutions for Surgical Preparation of the Vagina (Obstet Gynecol 2013;122:718–20)
ACOG Committee Opinion No. 580: Von Willebrand Disease in Women (Obstet Gynecol 2013;122:1368–73)
ACOG Committee Opinion No. 582: Addressing Health Risks of Noncoital Sexual Activity (Obstet Gynecol 2013;122:1378–83)
ACOG Committee Opinion No. 642: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy (Joint with the Long-Acting Reversible Contraception Working Group) (Obstet Gynecol 2015;126:e44–8)
ACOG Committee Opinion No. 645: Dual Therapy for Gonococcal Infections (Obstet Gynecol 2015;126:e95–9)
ACOG Practice Bulletin No. 78: Hemoglobinopathies in Pregnancy (Obstet Gynecol 2007;109:229–37)
ACOG Practice Bulletin No. 81: Endometrial Ablation (Obstet Gynecol 2007;109:1233–48)
ACOG Practice Bulletin No. 82: Management of Herpes in Pregnancy (Obstet Gynecol 2007;109:1489–98)
ACOG Practice Bulletin No. 84: Prevention of Deep Vein Thrombosis and Pulmonary Embolism (Obstet Gynecol 2007;110: 429–40) (Correction)
ACOG Practice Bulletin No. 92: Use of Psychiatric Medications During Pregnancy and Lactation (Obstet Gynecol 2008;111:1001–20)
ACOG Practice Bulletin No. 114: Management of Endometriosis (Obstet Gynecol 2010;116:223–36)
ACOG Practice Bulletin No. 134: Fetal Growth Restriction (Joint with the Society for Maternal–Fetal Medicine) (Obstet Gynecol 2013;121:1122–33)
ACOG Practice Bulletin No. 136: Management of Abnormal Uterine Bleeding Associated With Ovulatory Dysfunction (Obstet Gynecol 2013;122:176–85)
ACOG Practice Bulletin No. 152: Emergency Contraception (Obstet Gynecol 2015;126:e1–11)
ACOG Practice Bulletin No. 154: Operative Vaginal Delivery (Obstet Gynecol 2015;126:e56–65)
ACOG Practice Bulletin No. 155: Urinary Incontinence in Women (Joint with the American Urogynecologic Society) (Obstet Gynecol 2015;126:e66–81)
ACOG Practice Bulletin No. 156: Obesity in Pregnancy (Obstet Gynecol 2015;126:112–26) (Correction)
ACOG Practice Bulletin No. 161: External Cephalic Version (Obstet Gynecol 2016;127:e54–61)
ACOG Practice Bulletin No. 168: Cervical Cancer Screening and Prevention (Obstet Gynecol 2016;128:e111–30) (Interim Update)
ENDORSEMENTS
For more information on ACOG endorsed documents, please visit www.acog.org/Resources-And-Publications/Endorsed-Documents.
ENDORSED by ACOG
The following publication has been endorsed by the American College of Obstetricians and Gynecologists and should be construed as ACOG clinical guidance. ACOG’s endorsement is valid for 5 years unless the document is revised or withdrawn sooner.
Testing and interpreting measures of ovarian reserve: a committee opinion. Practice Committee of the American Society for Reproductive Medicine. Fertil Steril 2015103:e9–17. Available at: http://www.fertstert.org/article/S0015-0282(14)02518-7/pdf. Retrieved October 26, 2017.
Note: This corrects and replaces the 2012 citation for the endorsed document printed on the Breaker Page in the September 2017 issue of Obstetrics & Gynecology.
RESOURCES
ZIKA
Obstetrician–gynecologists and other obstetric care providers are encouraged to visit the following resources for detailed guidance and information regarding Zika, including breaking developments.
ACOG Zika Virus Web Page: www.acog.
    loading  Loading Related Articles